Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Autistic DisorderBehavioral Symptoms
Interventions
DRUG

Aripiprazole

Tablets, Oral, 2, 5, 10, or 15 mg, once daily, 52 weeks

Trial Locations (55)

10029

Seaver and New York Autism Center of Excellence, New York

10312

Richmond Behavioral Associates, Staten Island

11714

North Shore - Long Island Jewish Health System, Bethpage

15203

Western Psychiatric Institute and Clinic, Pittsburgh

20170

Neuroscience, Inc, Herndon

22031

Children's National Medical Center, Fairfax

22801

Mission Hospitals - Mission Children's Clinics, Asheville

23298

Virginia Treatment Center For Children, Richmond

23510

Monarch Research Associates, Norfolk

27710

Duke Child and Family Study Center, Durham

30342

Child Neurology Associates, PC, Atlanta

32607

Sarkis Clinical Trials, Gainesville

32611

University of Florida, Gainesville

32792

Children's Developmental Center, Winter Park

33155

Miami Children's Hospital, Miami

33432

Offices of Gregory Marsella, MD, PA, Boca Raton

33613

University of South Florida, Tampa

35203

University of Alabama at Birmingham, Birmingham

36303

Harmonex Neuroscience, Dothan

38105

UT Medical Group, Department Of Psychiatry, Memphis

40202

University of Louisville, Louisville

43210

The Nisonger Center, Columbus

44106

University Hospitals of Cleveland, Cleveland

48201

Children's Hospital Of Michigan, Detroit

48302

Neurobehavioral Medicine Group, Bloomfield Hills

53226

Children's Hospital of Wisconsin, Milwaukee

55101

Regions Hospital, Saint Paul

60608

University of Illinois at Chicago, Chicago

66160

Kansas University Medical Center, Kansas City

73116

Cutting Edge Research, Oklahoma City

75230

Dallas Pediatric Neurology Associates, Dallas

77007

Bayou City Research, Ltd., Houston

77090

Red Oak Psychiatry Associates, PA, Houston

78218

North San Antonio Healthcare Associates, San Antonio

80045

The Children's Hospital, Aurora

85006

Southwest Autism Research and Resource Center, Phoenix

89128

Center for Psychiatry and Behavioral Medicine, Las Vegas

90274

Peninsula Research Assoc, Rolling Hills Estate

92123

Sharp Mesa Vista Hospital, San Diego

92626

Clinical Innovations, Inc, Costa Mesa

95817

University Of California-Davis Health Science Center, Sacramento

98034

Pacific Institute of Medical Sciences, Bothell

98109

Autism Spectrum Treatment and Research Center, Seattle

85724-5002

Univ of Arizona, Tuscon

94305-5719

Stanford University School Of Medicine, Stanford

30080-6342

Institute For Behavioral Medicine, Smyrna

02138

Massachusetts General Hospital, Cambridge

02139

Cambridge Health Alliance, Cambridge

02481

Ladders Clinic, Wellsley

64108-4619

Children's Mercy Hospital and Clinics, Kansas City

68198-5380

Munroe-Meyer Institute Diagnostic Center, Omaha

08755

Children's Specialized Hospital, Toms River

11794-8790

SUNY at Stony Brook - School of Medicine, Stony Brook

27599-7160

University of NC, Chapel Hill

45267-0559

University of Cincinnati, Cincinnati

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY